DK2097753T3 - Allosteriske modulationer af SHIP-polypeptider og anvendelser deraf - Google Patents

Allosteriske modulationer af SHIP-polypeptider og anvendelser deraf

Info

Publication number
DK2097753T3
DK2097753T3 DK07855476.3T DK07855476T DK2097753T3 DK 2097753 T3 DK2097753 T3 DK 2097753T3 DK 07855476 T DK07855476 T DK 07855476T DK 2097753 T3 DK2097753 T3 DK 2097753T3
Authority
DK
Denmark
Prior art keywords
allosteric
modulations
polypeptides
ship
applications
Prior art date
Application number
DK07855476.3T
Other languages
English (en)
Inventor
Alice Mui
Christopher Ong
Gerald Krystal
Raymond Andersen
Original Assignee
British Columbia Cancer Agency
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by British Columbia Cancer Agency filed Critical British Columbia Cancer Agency
Application granted granted Critical
Publication of DK2097753T3 publication Critical patent/DK2097753T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/42Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving phosphatase
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pathology (AREA)
  • Genetics & Genomics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DK07855476.3T 2006-12-04 2007-12-04 Allosteriske modulationer af SHIP-polypeptider og anvendelser deraf DK2097753T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86845306P 2006-12-04 2006-12-04
PCT/CA2007/002194 WO2008067666A1 (en) 2006-12-04 2007-12-04 Allosteric modulation of ship polypeptides and uses thereof

Publications (1)

Publication Number Publication Date
DK2097753T3 true DK2097753T3 (da) 2012-11-19

Family

ID=39491620

Family Applications (1)

Application Number Title Priority Date Filing Date
DK07855476.3T DK2097753T3 (da) 2006-12-04 2007-12-04 Allosteriske modulationer af SHIP-polypeptider og anvendelser deraf

Country Status (4)

Country Link
EP (1) EP2097753B1 (da)
CA (1) CA2671618C (da)
DK (1) DK2097753T3 (da)
WO (1) WO2008067666A1 (da)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6978096A (en) * 1995-09-14 1997-04-01 Fred Hutchinson Cancer Research Center Dna encoding an sh2-inositol phosphatase, an shc-binding protein
WO2002024233A2 (en) * 2000-09-19 2002-03-28 University Of South Florida Control of nk cell function and survival by modulation of ship activity
CA2463136A1 (en) * 2001-10-17 2003-04-24 Raymond Andersen Ship 1 modulators

Also Published As

Publication number Publication date
WO2008067666A1 (en) 2008-06-12
WO2008067666A8 (en) 2008-09-18
CA2671618C (en) 2015-03-31
EP2097753A4 (en) 2010-03-10
WO2008067666A9 (en) 2009-03-12
CA2671618A1 (en) 2008-06-12
EP2097753A1 (en) 2009-09-09
EP2097753B1 (en) 2012-08-22

Similar Documents

Publication Publication Date Title
DK2069558T3 (da) Design og konstruktion af forskelligartede syntektiske peptid- og polypeptidbiblioteker
DK2155228T3 (da) Polypeptidinhibitorer af HSP27-kinase og anvendelser herfor
DK2124999T3 (da) Activin-actrii antagonister og anvendelser til behandling af anæmi
DK2059535T3 (da) Prlr-specifikt antistof og anvendelser deraf
DK2173378T3 (da) Komplekser af il-15 og il-15ralfa og anvendelser deraf
DK2147096T3 (da) Modificerede faktor-VII-polypeptider og anvendelser deraf
DK1991273T4 (da) Mærkning og påvisning af post-translationelt modificerede proteiner
DK3202779T3 (da) Hgh polypeptider med langtidsvirkning og anvendelser deraf
DK3020729T3 (da) Antistoffer mod human il-22 og anvendelser deraf
DK2570467T4 (da) Anvendelse af en sammensætning af tetrafluorpropen og carbonhydrider
DK2209806T3 (da) Anti-hepcidin-antistoffer og anvendelser deraf
DK2134330T3 (da) Kominationer af 5-ht2a-inverse agonister og antagonister med antipsykotika
DK2120604T3 (da) Fremgangsmåde til fraktionering af havre, produkter derved opnået, og anvendelser deraf
DK2084444T4 (da) Testning og udluftning af rør-annulus
DK1994055T3 (da) Anti-5t4-antistoffer og anvendelser deraf
DK2157967T3 (da) Suspensionsformuleringer af insulinotropiske peptider og anvendelser deraf
DK2012839T3 (da) Hidtil ukendte antimikrobielle substrater og anvendelser deraf
HK1147068A1 (en) Benzamide mglur5 positive allosteric modulators and methods of making and using same mglur5
BRPI0719369A2 (pt) Porta-prótese e aplicações do mesmo
DK2142529T3 (da) Trpv1-antagonister og anvendelser deraf
DK2118140T3 (da) Humancytomegalovirus-neutraliserende antistoffer og anvendelse deraf
DK2074205T3 (da) Detergentsammensætninger og anvendelsen af enzymkombinationer deri
DK2081955T3 (da) Metastinderivater og anvendelse deraf
DK2254598T3 (da) Kombination af alfa 7-nikotinagonister og antipsykotika
DK2114903T3 (da) Bicykliske pyrimidinoner og anvendelser deraf